![Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy | BMC Cancer | Full Text Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1471-2407-11-21/MediaObjects/12885_2010_Article_2514_Fig2_HTML.jpg)
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy | BMC Cancer | Full Text
![Survival curves of patients with neuroblastoma according to expression... | Download Scientific Diagram Survival curves of patients with neuroblastoma according to expression... | Download Scientific Diagram](https://www.researchgate.net/publication/5765043/figure/fig1/AS:267636663648303@1440820961978/Survival-curves-of-patients-with-neuroblastoma-according-to-expression-of-cell-adhesion.png)
Survival curves of patients with neuroblastoma according to expression... | Download Scientific Diagram
Kaplan-Meier survival analysis for patients with neuroblastoma in the... | Download Scientific Diagram
![Kaplan–Meier overall survival curves for patients with neuroblastoma,... | Download Scientific Diagram Kaplan–Meier overall survival curves for patients with neuroblastoma,... | Download Scientific Diagram](https://www.researchgate.net/publication/274398466/figure/fig5/AS:273728244285452@1442273307335/Kaplan-Meier-overall-survival-curves-for-patients-with-neuroblastoma-subdivided-by.png)
Kaplan–Meier overall survival curves for patients with neuroblastoma,... | Download Scientific Diagram
![Cancers | Free Full-Text | Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis Cancers | Free Full-Text | Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis](https://www.mdpi.com/cancers/cancers-13-04941/article_deploy/html/images/cancers-13-04941-g001.png)
Cancers | Free Full-Text | Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis
![Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015 | Pediatric Drugs Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015 | Pediatric Drugs](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40272-017-0251-3/MediaObjects/40272_2017_251_Fig6_HTML.gif)
Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015 | Pediatric Drugs
![Integrating Bulk-seq and Single-cell-seq Reveals Estrogen and MAPK Pathways Associating with Neuroblastoma Outcome - Xin Li, Yanlong Zheng, Qiao Ge, Zhenbo Dai, Dejun Zhou, Xiangdong Tian, 2023 Integrating Bulk-seq and Single-cell-seq Reveals Estrogen and MAPK Pathways Associating with Neuroblastoma Outcome - Xin Li, Yanlong Zheng, Qiao Ge, Zhenbo Dai, Dejun Zhou, Xiangdong Tian, 2023](https://journals.sagepub.com/cms/10.1177/10732748231178177/asset/images/large/10.1177_10732748231178177-fig4.jpeg)
Integrating Bulk-seq and Single-cell-seq Reveals Estrogen and MAPK Pathways Associating with Neuroblastoma Outcome - Xin Li, Yanlong Zheng, Qiao Ge, Zhenbo Dai, Dejun Zhou, Xiangdong Tian, 2023
![Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma - ScienceDirect Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804919307518-gr3.jpg)
Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma - ScienceDirect
![Kaplan–Meier overall survival curves for patients with neuroblastoma... | Download Scientific Diagram Kaplan–Meier overall survival curves for patients with neuroblastoma... | Download Scientific Diagram](https://www.researchgate.net/publication/274398466/figure/fig4/AS:273727661277185@1442273168107/Kaplan-Meier-overall-survival-curves-for-patients-with-neuroblastoma-with-single-copy-of.png)
Kaplan–Meier overall survival curves for patients with neuroblastoma... | Download Scientific Diagram
![A practical nomogram and risk stratification system for predicting survival outcomes in neuroblastoma patients: a SEER population-based study | Journal of Cancer Research and Clinical Oncology A practical nomogram and risk stratification system for predicting survival outcomes in neuroblastoma patients: a SEER population-based study | Journal of Cancer Research and Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00432-023-05110-5/MediaObjects/432_2023_5110_Fig2_HTML.png)
A practical nomogram and risk stratification system for predicting survival outcomes in neuroblastoma patients: a SEER population-based study | Journal of Cancer Research and Clinical Oncology
![Event‐free survival (A) and overall survival curves (B) for patients... | Download Scientific Diagram Event‐free survival (A) and overall survival curves (B) for patients... | Download Scientific Diagram](https://www.researchgate.net/publication/346462587/figure/fig3/AS:11431281180480298@1691628304881/Event-free-survival-A-and-overall-survival-curves-B-for-patients-with-low-risk-LR.png)
Event‐free survival (A) and overall survival curves (B) for patients... | Download Scientific Diagram
![Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial | Journal of Clinical Oncology Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/0/jco.ahead-of-print/jco.23.00458/20231228/images/keyimage.jpg)
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial | Journal of Clinical Oncology
![Biomolecules | Free Full-Text | Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG) Biomolecules | Free Full-Text | Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG)](https://www.mdpi.com/biomolecules/biomolecules-12-00018/article_deploy/html/images/biomolecules-12-00018-g001-550.jpg)
Biomolecules | Free Full-Text | Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG)
![Kaplan–Meier curves for neuroblastoma patients with and without TIAM1... | Download Scientific Diagram Kaplan–Meier curves for neuroblastoma patients with and without TIAM1... | Download Scientific Diagram](https://www.researchgate.net/publication/315940106/figure/fig1/AS:482641859354641@1492082194519/Kaplan-Meier-curves-for-neuroblastoma-patients-with-and-without-TIAM1-variants-A.png)
Kaplan–Meier curves for neuroblastoma patients with and without TIAM1... | Download Scientific Diagram
![Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study - The Lancet Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study - The Lancet](https://www.thelancet.com/cms/attachment/2000995621/2003688051/gr1.jpg)
Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study - The Lancet
![Clinical Features of Neuroblastoma with 11q Deletion: An Increase in Relapse Probabilities in Localized and 4S Stages | Scientific Reports Clinical Features of Neuroblastoma with 11q Deletion: An Increase in Relapse Probabilities in Localized and 4S Stages | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-50327-5/MediaObjects/41598_2019_50327_Fig1_HTML.png)